UCSD develops tech to isolate drug-delivery nanoparticles from the blood

Researchers from the University of California, San Diego, have developed technology to isolate drug-delivery nanoparticles from blood. The university says the platform, which relies on an oscillating electric field, has applications toward medicine, as well as industrial uses. More

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.